TGFB1 and pancreatic adenocarcinoma: Interestingly, TGF-β has been reported to be a negative regulator of lymphangiogenesis in other cancer types, as shown in mouse xenograft models of pancreatic adenocarcinoma, where inhibition of endogenous TGF-β signaling induced lymphangiogenesis [58].